Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Replimune Group, Inc. (NASDAQ: REPL) is drawing attention in the healthcare sector, particularly within the biotechnology industry, due to its unique approach to cancer treatment. With a market capitalization of..
Enhabit, Inc. (NASDAQ: EHAB), a prominent player in the healthcare sector, operates within the medical care facilities industry. Headquartered in Dallas, Texas, Enhabit is renowned for its comprehensive home health..
Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector, specifically within the medical devices industry, presents a compelling case for investors eyeing significant upside potential. Headquartered in..
For individual investors with an eye on the biotechnology sector, Geron Corporation (NASDAQ: GERN) presents an intriguing opportunity. With a market capitalization of $778.38 million, this U.S.-based biopharmaceutical company is..
As the healthcare sector continues to be a focal point for investors, Vir Biotechnology, Inc. (NASDAQ: VIR) stands out with a remarkable potential upside of 197.96%. This San Francisco-based biopharmaceutical..
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a promising player in the biotechnology sector, has caught the attention of investors with its significant potential upside of 179.80%. Based in Cambridge, Massachusetts, this..
Inventiva S.A. (NASDAQ: IVA), a clinical-stage biopharmaceutical company headquartered in Daix, France, is making waves in the biotechnology sector with its innovative approach to treating metabolic and fibrotic diseases. As..
AbCellera Biologics Inc. (NASDAQ: ABCL), a prominent player in the biotechnology sector, is capturing significant attention with its innovative approach to developing antibody-based medicines. Headquartered in Vancouver, Canada, the company..
AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company based in San Diego, California, has captured investors’ attention with its impressive potential upside of 82.62%, according to current analyst ratings. Specializing..
Ardelyx, Inc. (NASDAQ: ARDX), a burgeoning player in the biotechnology sector, has captured the attention of investors with its promising pipeline and significant upside potential. With a market capitalization of..
Tectonic Therapeutic, Inc. (NASDAQ: TECX), a pioneering biotechnology company, stands at the forefront of therapeutic innovation with its cutting-edge GEODe technology platform. Specializing in the development of therapeutic proteins and..
Talkspace, Inc. (NASDAQ: TALK), a pioneering virtual behavioral healthcare company, is capturing investor attention with a potential upside of 79.10%. Operating within the healthcare sector, Talkspace offers a digital platform..
Claritev Corporation (NYSE: CTEV) is capturing investor attention in the healthcare sector, particularly in the Health Information Services industry. With a market capitalization of $1.09 billion, this New York-based company..
Keros Therapeutics, Inc. (NASDAQ: KROS) is emerging as a compelling opportunity in the biotech sector, with an impressive potential upside of 54.57% according to recent analyst ratings. As a clinical-stage..
Cullinan Therapeutics, Inc. (NASDAQ: CGEM) is capturing the attention of investors with its significant potential upside, as analysts forecast a compelling 239.23% increase from its current price of $7.73. This..
Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the healthcare sector, specializes in medical devices that cater to a diverse range of health needs. Headquartered in Alpharetta, Georgia, Avanos..
HealthStream, Inc. (NASDAQ: HSTM), a prominent player in the healthcare sector, specializes in providing innovative Software-as-a-Service (SaaS) solutions tailored for healthcare organizations across the United States. With a primary focus..
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a pioneering company in the biotechnology sector, is capturing investor attention with an impressive market capitalization of $948.82 million. Based in New York, this..
Sana Biotechnology, Inc. (NASDAQ: SANA) is capturing attention in the healthcare sector with a distinct focus on pioneering engineered cell therapies. As a U.S.-based biotechnology company, Sana is at the..
